Cardiac Function Circulation Pharmacology 
European Journal of Heart Failure
OCTOBER 17, 2023
Abstract Aims Neutrophil activity contributes to adverse cardiac remodelling in experimental acute cardiac injury and is modifiable with pharmacologic agents like colchicine. HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction.
Circulation
NOVEMBER 11, 2024
Circulation, Volume 150, Issue Suppl_1 , Page A4140419-A4140419, November 12, 2024. Cardiac fibrosis is a pathological hallmark of almost all forms of heart disease, characterized by excessive deposition of extracellular matrix (ECM) proteins by activated fibroblasts, leading to cardiomyocyte hypertrophy, arrhythmias, and heart failure.
Circulation
NOVEMBER 14, 2023
Circulation, Ahead of Print. Estrogen-related receptors ERRα and ERRγ are essential regulators of cardiac metabolism. We investigated the effect of ERR agonist on cardiac function in a pressure overload–induced HF model in vivo. BACKGROUND:Cardiac metabolic dysfunction is a hallmark of heart failure (HF).
Journal of Cardiovascular Pharmacology
JULY 23, 2024
Serial echocardiography and pressure-volume loops were utilized to assess cardiac function and hemodynamics. Mechanistically, combination therapy effectively suppressed circulating and cardiac expression of aldosterone- and apoptosis-associated proteins.
DAIC
DECEMBER 12, 2023
That’s the subject of a new study by a team that includes two USF Health doctors who reported their findings in Circulation , the flagship journal of the American Heart Association. “An The damage to the heart muscle is usually permanent, leaving the heart unable to pump the way it should.
Expert insights. Personalized for you.
40 
Let's personalize your content